Loading…

Leishmania donovani inhibits inflammasome‐dependent macrophage activation by exploiting the negative regulatory proteins A20 and UCP2

In visceral leishmaniasis, we found that the antileishmanial drug Amp B produces a higher level of IL‐1β over the infected control. Moreover, administering anti‐IL‐1β antibody to infected Amp B–treated mice showed significantly less parasite clearance. Investigation revealed that Leishmania inhibits...

Full description

Saved in:
Bibliographic Details
Published in:The FASEB journal 2017-11, Vol.31 (11), p.5087-5101
Main Authors: Gupta, Anand Kumar, Ghosh, Kuntal, Palit, Shreyasi, Barua, Jayita, Das, Pijush K., Ukil, Anindita
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In visceral leishmaniasis, we found that the antileishmanial drug Amp B produces a higher level of IL‐1β over the infected control. Moreover, administering anti‐IL‐1β antibody to infected Amp B–treated mice showed significantly less parasite clearance. Investigation revealed that Leishmania inhibits stimuli‐induced expression of a multiprotein signaling platform, NLRP3 inflammasome, which in turn inhibits caspase‐1 activation mediated maturation of IL‐1β from its pro form. Attenuation of NLRP3 and pro‐IL‐1β in infection was found to result from decreased NF‐κB activity. Transfecting infected cells with constitutively active NF‐κB plasmid increased NLRP3 and pro‐IL‐1β expression but did not increase mature IL‐1β, suggesting that IL‐1β maturation requires a second signal, which was found to be reactive oxygen species (ROS). Decreased NF‐κB was attributed to increased expression of A20, a negative regulator of NF‐κB signaling. Silencing A20 in infected cells restored NLRP3 and pro‐IL‐1β expression, but also increased matured IL‐1β, implying an NF‐κB‐independent A20‐modulated IL‐1β maturation. Macrophage ROS is primarily regulated by mitochondrial uncoupling protein 2 (UCP2), and UCP2‐silenced infected cells showed an increased IL‐1β level. Short hairpin RNA‐mediated knockdown of A20 and UCP2 in infected mice independently documented decreased liver and spleen parasite burden and increased IL‐1β production. These results suggest that Leishmania exploits A20 and UCP2 to impair inflammasome activation for disease propagation.—Gupta, A. K., Ghosh, K., Palit, S., Barua, J., Das, P. K., Ukil, A. Leishmania donovani inhibits inflammasome‐dependent macrophage activation by exploiting the negative regulatory proteins A20 and UCP2. FASEB J. 31, 5087–5101 (2017). www.fasebj.org
ISSN:0892-6638
1530-6860
DOI:10.1096/fj.201700407R